AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $67,000 | -65.3% | 26,550 | +86.4% | 0.00% | -100.0% |
Q2 2020 | $193,000 | -35.0% | 14,240 | -57.7% | 0.00% | -50.0% |
Q3 2018 | $297,000 | -82.5% | 33,655 | -80.2% | 0.00% | -77.8% |
Q2 2018 | $1,694,000 | +170.2% | 169,725 | +157.9% | 0.01% | +125.0% |
Q1 2018 | $627,000 | -27.2% | 65,805 | +13.7% | 0.00% | -20.0% |
Q4 2017 | $861,000 | -17.4% | 57,880 | +9.1% | 0.01% | -16.7% |
Q3 2017 | $1,043,000 | – | 53,040 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |